Analysis of the utilization and cost of antibiotics at an intensive care unit in Surabaya
Abstract
Keywords
Full Text:
PDFReferences
Adisasmito, A.W., & Tumbelaka, A.R., 2006, Penggunaan antibiotik khususnya pada infeksi bakteri gram negatif di ICU anak RSAB Harapan Kita, Sari Pediatri. 8(2):127-34.
Anggriani, Y., Banun, A., Erliana., 2013, Evaluasi penggunaan antibiotika di ruang HCU dan ruang ICU rumah sakit kanker “Dharmais†Februari-Maret 2012, Jurnal Ilmu Kefarmasian Indonesia. 11 (2):182-90.
Cucu, A., Nica, M., Ceausu, E., Cioran, N., 2014, Antimicrobial resistance profile in infectious disease hospital intensive care unit, FARMACIA. 62(4):767-76.
Dulhunty, J.M., Roberts, J.A., Davis, J.S., Webb, S.A., Bellomo, R., Gomersall, C., et al., 2013, Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial, Clin Infect Dis. 56(2):236-44.
Dwijayanti, S., Irawati, S., Setiawan, E., 2016, Profil kompatibilitas sediaan obat intravena dengan pelarut pada pasien intensive care unit, Jurnal Farmasi Klinik Indonesia. 5(2): 84-97.
Eachempati, S.R., Hydo, L.J., Shou, J., Barie, P.S., 2009, Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?, J Trauma. 66(5):1343-8.
Garnacho-Montero, J., Gutiérrez-Pizarraya, A., Escoresca-Ortega, A., Corcia-Palomo, Y., Fernández-Delgado, E., Herrera-Melero, I., et al., 2014, De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock, Intensive Care Med. 40(1):32-40.
Goncalves-Pereira, J., & Povoa, P., 2011, Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams. Crit Care. 15(5):R206.
Gonzalez, L., Cravoisy, A., Barraud, D., Conrad, M., Nace, L., Lemarié, J., et al., 2013, Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patiens, Crit Care. 17(4):R140.
Hanberger, H., Walther, S., Leone, M., Barie, P.S., Rello, J., Lipman, J., et al., 2011, Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: result from The EPIC II study, Int J Antimicrob Agents. 38(4):331-5.
Heenen, S., Jacobs, F., Vincent, J.L., 2012, Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?, Crit Care Med. 40(5):1404-9.
Khan, R.A., Bakry, M.M., Islahudin, F., 2015, Appropriate antibiotic administration in critically ill patients with pneumonia, Indian J Pharm Sci. (3): 299-305.
Luciana, Andrajati, R., Rianti, A., Khan, A.H., 2015, Rational antimicrobial use in an intensive care unit in Jakarta, Indonesia: a hospital-based, cross-sectional study, Trop J Pharm Res. 14(4):707-14.
Marcon, A.P., Gamba, M.A., Vianna, L.A., 2006, Nosocomial diarrhea in the intensive care unit, Braz J Infect Dis. 10(6):384-9.
Marquet, K., Liesenborgs, A., Bergs, J., Vleugels, A., Claes, N., 2015, Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis, Crit Care. 19:63.
McKinnon, P.S., Paladino, J.A., Schentag, J.J., 2008, Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections, Int J Antimicrob Agents. 31(4):345-51.
Owens, R.C. Jr., Donskey, C.J., Gaynes, R.P., Loo, V.G., Muto, C.A., 2008, Antimicrobial-associated risk factors for Clostridium defficile, Clin Infect Dis. 46 Suppl 1:S19-31.
Paul, M., Kariv, G., Goldberg, E., Raskin, M., Shaked, H., Hazzan, R., et al., 2010, Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia, J Antimicrob Chemother. 65(12):2658-65.
Roberts, J.A., & Lipman, J., 2009, Pharmacokinetic issues for antibiotics in the critically ill patient, Crit Care Med. 37(3):840-51.
Rubio-Terres, C., Garau, J., Grau, S., Martinez-Martinez, L., 2010, Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study, Clin Microbiol Infect. 16(6): 722-8.
Talpaert, M.J., Gopal Rao, G., Cooper, B.S., Wade, P., 2011, Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection, J Antimicrob Chemother. 66(9):2168-74.
Trissel, L.A., 2013, Handbook on injectable drugs, 17th edition. Bethesda: American Society of Health-System Pharmacists.
Williams, D.J., Hall, M., Shah, S.S., Parikh, K., Tyler, A., Neuman, M.I., et al., 2013, Narrow vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia, Pediatrics. 132(5): e1141–e1148.
Zilberberg, M.D., Shorr, A.F., Micek, S.T., Mody, S.H., Kollef, M.H., 2008, Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience, Chest. 134(5):963-8.
DOI: http://dx.doi.org/10.12928/pharmaciana.v7i2.6767
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Eko Setiawan, Hidayat Felix, Adji Prayitno Setiadi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Office: Faculty of Pharmacy, Universitas Ahmad Dahlan
Jl. Prof. Dr. Soepomo, S.H., Janturan, Warungboto, Umbulharjo, Yogyakarta, Indonesia
Kode pos 55164
Email: pharmaciana@pharm.uad.ac.id